Planta Med 2009; 75(4): 316-320
DOI: 10.1055/s-0028-1112213
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Regulatory Role of Ginsenoside Rp1, a Novel Ginsenoside Derivative, on CD29-Mediated Cell Adhesion

Byung Hun Kim1 , Jae Youl Cho1
  • 1School of Bioscience and Biotechnology, and Institute of Bioscience and Biotechnology, Kangwon National University; Chuncheon, Korea
Further Information

Publication History

Received: September 27, 2008 Revised: November 4, 2008

Accepted: November 10, 2008

Publication Date:
22 January 2009 (online)

Preview

Abstract

In this study, we examined the regulatory role of G-Rp1 on cell adhesion events mediated by β1-integrins (CD29). Using a U937 cell-cell adhesion assay, we found that exogenous G-Rp1 down-regulates CD29 activation in a dose-dependent manner, whereas G-Rg3 did not cause the same effect. However, G-Rp1 increased cell-fibronectin adhesion comparable to cytochalasin B, an actin cytoskeleton disruptor. Furthermore, G-Rp1 also blocked the rearrangement of actin at sites of cell-cell contact, indicating that the actin cytoskeleton may be a target of G-Rp1 action. Interestingly, G-Rp1 suppressed dephosphorylation of vasodilator-stimulated phosphoprotein (VASP) at Ser-157, known to be an actin cytoskeleton modulatory protein. These results suggest that G-Rp1 may act as a novel regulator of CD29-mediated cell adhesion events, which are involved in numerous pathological symptoms.

References

Jae Youl Cho, PhD

School of Bioscience and Biotechnology and

Institute of Bioscience and Biotechnology

Kangwon National University

Chuncheon 200–701

Korea

Phone: +82-33-250-6488

Fax: +82-33-253-6560

Email: jaecho@kangwon.ac.kr